All lobbying filings
SAREPTA THERAPEUTICS, INC.
SAREPTA THERAPEUTICS, INC. filed a Q2 report for SAREPTA THERAPEUTICS, INC. on July 16, 2025.
Lobbying for SAREPTA THERAPEUTICS, INC.
Filing · LD-2 quarterly report
Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 16, 2025
Expenses
$260,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
California
Government bodies contacted
2
Lobbying activity
3
Issues related to rare diseases such as Duchenne Muscular Dystrophy Issues related to patient access to treatments Issues related to newborn screening for rare diseases
Issues related to scientific innovation in healthcare such as gene therapies Issues related to artificial intelligence and data governance
Tax issues related to research and development